RFG Advisory’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Buy
6,835
+4,617
+208% +$1.28M 0.02% 449
2026
Q1
$655K Sell
2,218
-2,064
-48% -$613K 0.01% 660
2025
Q4
$1.17M Buy
4,282
+412
+11% +$112K 0.02% 488
2025
Q3
$1.05M Buy
3,870
+1,271
+49% +$346K 0.02% 479
2025
Q2
$716K Buy
+2,599
New +$707K 0.02% 515
2020
Q3
Sell
-1,255
Closed -$204K 409
2020
Q2
$204K Sell
1,255
-82
-6% -$14.7K 0.03% 364
2020
Q1
$231K Sell
1,337
-196
-13% -$39K 0.04% 301
2019
Q4
$308K Sell
1,533
-67
-4% -$13.7K 0.05% 279
2019
Q3
$338K Buy
1,600
+268
+20% +$56K 0.07% 224
2019
Q2
$259K Buy
+1,332
New +$246K 0.06% 257

Other funds holding CME

RFG Advisory's CME Position: Q2 2026 in Review

RFG Advisory increased its CME Group (CME) stake by 208% in Q2 2026, buying an estimated $1.28M and bringing the position to 6,835 shares worth $1.51M. The position accounts for 0.02% of the portfolio, ranked #449.

RFG Advisory first reported a position in CME in Q2 2019 and has held it in 10 quarters since. 439 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • RFG Advisory held 6,835 shares of CME Group worth $1.51M as of Q2 2026.
  • RFG Advisory bought 4,617 CME Group shares in Q2 2026, an estimated $1.28M.
  • CME Group made up 0.02% of RFG Advisory's portfolio in Q2 2026, its #449 holding.
  • RFG Advisory first reported a position in CME Group in Q2 2019 and has held it in 10 quarters since.
  • 439 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.